Seasonal Influenza Vaccine Market Report 2025 (Global Edition)

Global Seasonal Influenza Vaccine Market Report 2025 Market Size Split by Product Type (Type A (H1N1), Type A (H3N2), Type B), by Age Group (Paediatrics, Adolescence, Adults, Elderly), by Vaccine Type...

Seasonal Influenza Vaccine Market Report Description

We have various report editions of Seasonal Influenza Vaccine Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.

The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.

Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.

Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.

Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.

Seasonal Influenza Vaccine Market Insights Video

Competitive Analysis of the Seasonal Influenza Vaccine Market:

Company Recent Developments:

• The effectiveness of seasonal influenza vaccine against the h3n2 influenza virus

In 2023,H3N2 VIRUS is a non-human influenza virus that normally circulates in pigs and that has infected humans. Influenza A (H3N3) is responsible for the present rise in flu cases as notified by ICMR. Both H1N1 and H3N2 sub-types are variants of influenza A which change genetically as well as antigenically to produce new variants. H3N2 tends to change more rapidly, both genetically and antigenically, compared to H1N1. H3N2 is the cause behind the rise in flu cases that we have been seeing recently.

• The development of universal vaccines represents an emerging trend in influenza

In June 2023,Universal influenza vaccines are created to provide protection against more strains of the virus than quadrivalent influenza vaccines. The antibodies produced as a result of these universal influenza vaccinations should be able to recognize conserved epitopes on the surface of various influenza strains. This would be particularly advantageous in the event of an influenza pandemic arising from a new strain.

Top Companies Market Share in Seasonal Influenza Vaccine Industry: (In no particular order of Rank)

• Sanofi
• Merck & Co
• Novartis
• GlaxoSmithKline
• Changsheng Bio-Technology Co.
• Abbott Laboratories
• Aleph Biomedical
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Seasonal Influenza Vaccine Market Regional Analysis

Region and country analysis section of Seasonal Influenza Vaccine Industry Analysis has been segmented into 5 major region such as North America, Europe, Asia Pacific, Middle East & Africa ,and Latin America (along with respective major contributing countries) and provides the revenue share, current trends.

The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of Seasonal Influenza Vaccine market.

The current report Scope analyzes Seasonal Influenza Vaccine Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

Seasonal Influenza Vaccine Market Analysis

Type A (h1n1) was the leading category of Seasonal Influenza Vaccine market category.

The most common seasonal influenza is Type A (h1n1), and the market for type A seasonal influenza vaccine is on an exponential rise.

Seasonal Influenza Vaccine Market, by Type

• Type A (H1N1)
• Type A (H3N2)
• Type B 

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Seasonal Influenza Vaccine Industry. Request a Free Sample PDF!

By Age, Adult segment dominates the Seasonal Influenza Vaccine market.

The various types of seasonal influenza vaccine are prepared for different age group people. The different set of vaccine are available for the adult which fall in the age group from 18- 64 years. The people with certain chronic health conditions and pregnant women are advice to take the influenza vaccine. Only the people having life threating allergy to the vaccine or its component are advice not to take the vaccine.

Pediatrics

The Seasonal Influenza Vaccine reduces the risk of flu-associated complications and hospitalization among children. It is recommended that the children above the 6 months of age should be vaccinated every year in the fall i.e., by the end of October. The children ranging between the age group from 6 month to 8 years may require 2 doses of influenza vaccines for best protection.

Seasonal Influenza Vaccine market by Age segment analysis

• Paediatrics
• Adolescence
• Adults
• Elderly

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Seasonal Influenza Vaccine Vaccine Type Segment Analysis

What is the Quadrivalent Flu Vaccines Market size?

Quadrivalent Flu Vaccines

In 2016, the Quadrivalent Flu Vaccines Revenue (USD Million) was USD 3,276.45 Million and is expected to reach USD 9,511.01 Million in 2030.

Quadrivalent flu vaccines are capable of protecting against four different strains of the flu virus which includes two influenza A viruses and two influenza B viruses and hence can offers broader protection from infection. The Regular standard-dose quadrivalent shot are available for the population of age 6 months and older

Trivalent Flu Vaccines

Trivalent flu vaccines offer the protection from three strains of the virus which includes influenza A (H1N1), influenza A (H3N2), an influenza B virus. This vaccine is intended to administer in the muscle of arms via needle and is indicated for the people ranging in the age group of 10-64.

• Quadrivalent
• Trivalent
• High-Dose

Seasonal Influenza Vaccine End-users Segment Analysis

As per Analysis ,Hospitals segment accounted for 68.09% share of total Seasonal influenza vaccine market in 2030

Hospitals segment accounted for 68.09% share of total Seasonal influenza vaccine market in 2030. Hospitals is a term use for a residential establishment which provides short-term and long-term medical care consisting of observational, diagnostic, therapeutic and rehabilitative services for persons suffering or suspected to be suffering from a disease or injury and for patients. Hospital generally provides wide range of various type of healthcare and care for patients with various disease condition such as orthopedic, cardiology, dental, gynecology etc.

Clinics

Specialist clinics refers to the services provided to the outpatients. These are generally associated with hospital or medical school, that is devoted to the diagnosis and care of outpatients

Ambulatory care centers

It is a modern healthcare facility which offers the same-day surgical care, including diagnostic and preventive procedures. These centers provide diagnostic or primary health care services to the patients who have already seen a health care provider and selected surgery as the appropriate treatment for their condition.

• Hospitals
• Clinics
• Ambulatory care centers

The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of this market.

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion